Tenax Therapeutics Inc
TENX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$90.34M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $90.34 Million |
|---|---|
| Enterprise Value | $-23,393,651.00 |
| Earnings per Share | $-1.34 |
| Beta | 0.97 |
| Outstanding Shares | 53,452,869 |
Return
| Return on Equity | -60.52% |
|---|---|
| Return on Assets | -56.20% |
| Return on Invested Capital | 18.85% |
Valuation & Multiples
| P/E Ratio | -1.21 |
|---|---|
| PEG | -21.2 |
| Price to Sales | - |
| Price to Book Ratio | 0.85 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.36 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 5, 2026
EPS Estimate
$-0.35
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
March 9, 2027
EPS Estimate
$-0.34
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 18.31% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.00%▼ 58.77% |
|---|---|
| Total Invested | $957,765▼ 99.78% |
| Investors Holding | 5▼ 124.00% |
About Tenax Therapeutics Inc
CEO: John Kelley
